452 related articles for article (PubMed ID: 31705501)
1. Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells.
van Hugte E; Nadif Kasri N
Adv Exp Med Biol; 2019; 1192():297-312. PubMed ID: 31705501
[TBL] [Abstract][Full Text] [Related]
2. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
[TBL] [Abstract][Full Text] [Related]
3. Modeling neuropsychiatric disorders using human induced pluripotent stem cells.
Wang M; Zhang L; Gage FH
Protein Cell; 2020 Jan; 11(1):45-59. PubMed ID: 31134525
[TBL] [Abstract][Full Text] [Related]
4. Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.
Logan S; Arzua T; Canfield SG; Seminary ER; Sison SL; Ebert AD; Bai X
Compr Physiol; 2019 Mar; 9(2):565-611. PubMed ID: 30873582
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomics analysis of iPSC-derived neurons and modeling of neuropsychiatric disorders.
Lin M; Lachman HM; Zheng D
Mol Cell Neurosci; 2016 Jun; 73():32-42. PubMed ID: 26631648
[TBL] [Abstract][Full Text] [Related]
6. Modeling of psychiatric disorders using induced pluripotent stem cell-related technologies.
Nakazawa T; Hashimoto R; Takuma K; Hashimoto H
J Pharmacol Sci; 2019 Aug; 140(4):321-324. PubMed ID: 31257060
[TBL] [Abstract][Full Text] [Related]
7. [Modeling neurological and psychiatric disorders in vitro using induced pluripotent stem cells: highlighting findings in Alzheimer's disease and schizophrenia].
Hathy E; Kalman S; Apati A; Nemoda Z; Rethelyi JM
Neuropsychopharmacol Hung; 2016 Dec; 18(4):188-198. PubMed ID: 28259862
[TBL] [Abstract][Full Text] [Related]
8. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
9. Disease signatures for schizophrenia and bipolar disorder using patient-derived induced pluripotent stem cells.
Watmuff B; Berkovitch SS; Huang JH; Iaconelli J; Toffel S; Karmacharya R
Mol Cell Neurosci; 2016 Jun; 73():96-103. PubMed ID: 26777134
[TBL] [Abstract][Full Text] [Related]
10. Application of induced pluripotent stem cells to understand neurobiological basis of bipolar disorder and schizophrenia.
Liu YN; Lu SY; Yao J
Psychiatry Clin Neurosci; 2017 Sep; 71(9):579-599. PubMed ID: 28393474
[TBL] [Abstract][Full Text] [Related]
11. In vivo modeling of neuronal function, axonal impairment and connectivity in neurodegenerative and neuropsychiatric disorders using induced pluripotent stem cells.
Korecka JA; Levy S; Isacson O
Mol Cell Neurosci; 2016 Jun; 73():3-12. PubMed ID: 26691153
[TBL] [Abstract][Full Text] [Related]
12. Generation of Cortical, Dopaminergic, Motor, and Sensory Neurons from Human Pluripotent Stem Cells.
Tay SH; Winanto ; Khong ZJ; Koh YH; Ng SY
Methods Mol Biol; 2022; 2549():359-377. PubMed ID: 33959917
[TBL] [Abstract][Full Text] [Related]
13. Human iPSC-Derived Glia as a Tool for Neuropsychiatric Research and Drug Development.
Heider J; Vogel S; Volkmer H; Breitmeyer R
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638595
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic Autism: Cellular and Molecular Phenotypes in Pluripotent Stem Cell-Derived Neurons.
Liu X; Campanac E; Cheung HH; Ziats MN; Canterel-Thouennon L; Raygada M; Baxendale V; Pang AL; Yang L; Swedo S; Thurm A; Lee TL; Fung KP; Chan WY; Hoffman DA; Rennert OM
Mol Neurobiol; 2017 Aug; 54(6):4507-4523. PubMed ID: 27356918
[TBL] [Abstract][Full Text] [Related]
15. Modeling Psychiatric Disorder Biology with Stem Cells.
Das D; Feuer K; Wahbeh M; Avramopoulos D
Curr Psychiatry Rep; 2020 Apr; 22(5):24. PubMed ID: 32318888
[TBL] [Abstract][Full Text] [Related]
16. Targeting NMDA receptors in neuropsychiatric disorders by drug screening on human neurons derived from pluripotent stem cells.
Zhang W; Ross PJ; Ellis J; Salter MW
Transl Psychiatry; 2022 Jun; 12(1):243. PubMed ID: 35680847
[TBL] [Abstract][Full Text] [Related]
17. Induced Pluripotent Stem Cells in Disease Modeling and Gene Identification.
Kumar S; Blangero J; Curran JE
Methods Mol Biol; 2018; 1706():17-38. PubMed ID: 29423791
[TBL] [Abstract][Full Text] [Related]
18. Understanding neurodevelopmental disorders using human pluripotent stem cell-derived neurons.
Tamburini C; Li M
Brain Pathol; 2017 Jul; 27(4):508-517. PubMed ID: 28585386
[TBL] [Abstract][Full Text] [Related]
19. Induced pluripotent stem cells as a tool to study brain circuits in autism-related disorders.
Vitrac A; Cloëz-Tayarani I
Stem Cell Res Ther; 2018 Aug; 9(1):226. PubMed ID: 30139379
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9-mediated Knockout of the Neuropsychiatric Risk Gene KCTD13 Causes Developmental Deficits in Human Cortical Neurons Derived from Induced Pluripotent Stem Cells.
Kizner V; Naujock M; Fischer S; Jäger S; Reich S; Schlotthauer I; Zuckschwerdt K; Geiger T; Hildebrandt T; Lawless N; Macartney T; Dorner-Ciossek C; Gillardon F
Mol Neurobiol; 2020 Feb; 57(2):616-634. PubMed ID: 31402430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
